Would be interested to see RBS Morgans revised research post BH results
From their research post Cornea which was posted in full at the start of this thread by RichE
"o With the MEO share price at 44 cents, our relative valuation for MOG improves to 30 cents for Artemis exposure alone. This is slightly higher than previously advised due to the lower number of MOG shares issued than previously anticipated (288m vs 310m) and a higher MEO share price."
MOG Price at posting:
16.5¢ Sentiment: Hold Disclosure: Held
